Haemostasis capacity in the north-east of England has enjoyed significant benefits through collaboration with Stago UK. Here, staff from the South Tyne region explain how this collaboration has borne fruit in terms of compliance and efficiency.
The Queen Elizabeth Hospital in Gateshead oversees a highly efficient centre of excellence for pathology services across the South Tyne region. The central hub was established seven years ago as part of a £12 million redevelopment. This includes an integrated blood sciences unit, with significantly expanded haemostasis testing capacity. Working closely with Stago UK, all specialist testing can now be carried out in-house. The laboratory credits its long-standing partnership with Stago as integral to its continued success.
Bringing all specialist testing back into the Gateshead central hub required substantial changes to laboratory workflow. A key performance indicator (KPI) for Stago was to make sure this was achieved without disruption to routine testing turnaround times (TAT) and quality control (QC) compliance.
Testing at Gateshead now includes Stago assays for thrombophilia and lupus anticoagulant screening; monitoring of the new direct oral anticoagulants; factor assays and Stago’s unique solution for diagnosing von Willebrand disease, which can detect and distinguish between quantitative and qualitative von Willebrand factor (VWF) deficiencies.
Log in or register FREE to read the rest
This story is Premium Content and is only available to registered users. Please log in at the top of the page to view the full text.
If you don't already have an account, please register with us completely free of charge.
Register
